Investment opportunities

Four projects in one portfolio, each able to stand on its own. Investment is open to the full portfolio or to selected projects.

Scientist pouring a sample into a test tube

Beyond distribution: own, manufacture, care

projects in one portfolio, each able to stand on its own

The traditional model imports finished products and earns a margin on them. This portfolio keeps the value in the Kingdom: equity in drug development, local manufacturing under licence, and services that deliver care directly.

01
Compact specialised centres
Compact specialised centres in healthy ageing, mental and neurological health and addiction treatment, run to the protocols of international partners and designed to be repeated from city to city.
Partner agreement signed
02
Innovation and intellectual property
An equity stake in an international drug development company, and a proposed innovation centre in Riyadh.
Agreement signed
03
Localising medical manufacturing
A Saudi plant assembling newborn hearing screening devices under licence, serving the national newborn screening programme.
Licence under discussion
04
Bone bank
A licensed tissue bank to procure, process, preserve and distribute bone grafts inside the Kingdom.
Planning stage

All four are in the planning stage, ahead of feasibility studies, with five international partners and two agreements signed to date. Investment is open to the full portfolio or to selected projects.

Request the executive summary

The executive summary is confidential and for discussion only; it is not an offer of securities. Figures are preliminary management estimates prepared before feasibility studies and may change. Any investment is made only under definitive agreements.

For investors

How an investment proceeds

The plan starts with the cash-generating assets, so that their income supports the growth of the portfolio.

Three phases

Cash-generating assetsThe device plant and the bone bank are built, licences completed, and the first centre opens in Riyadh.
Expansion and replicationCentres open in other cities, the innovation centre starts operating, and the plant's production line grows.
Intellectual propertyPatent returns from the innovation centre, with a partial exit or a public offering considered.

Investor protections

Phased drawdownCapital is drawn in stages tied to licensing, fit-out and operating milestones.
Investor rightsPriority in distributions, pre-emption in later rounds and protection from dilution.
GovernanceA joint board, quarterly reports and an accredited external auditor.

Next steps

Model reviewA detailed session on each project's financial model and its assumptions.
Site visitsMeet the international partners and visit the proposed sites.
Data roomSigned agreements, transaction documents and the available studies.
Term sheetAgree the investment size, structure and timetable.

To begin, request the executive summary.

Next step